Literature DB >> 17624770

Optimization for the production of exopolysaccharide from Fomes fomentarius in submerged culture and its antitumor effect in vitro.

Wei Chen1, Zhao Zhao, Shi-Fei Chen, Yong-Quan Li.   

Abstract

A medicinal mushroom Fomes fomentarius, was isolated from the fruiting body of a wild F. fomentarius and identified by ITS-5.8S rDNA sequencing analysis. Then, the optimization of submerged culture conditions and nutritional requirements of mycelial biomass and exopolysaccharide (EPS) production from F. fomentarius was studied using orthogonal matrix method. Under the optimal culture condition, the maximum EPS concentration reached 3.64 g l(-1), which is about four times higher than that at the basal medium. Furthermore, the EPS from F. fomentarius has a direct antiproliferative effect in vitro on SGC-7901 huaman gastric cancer cells in a dose- and time-dependent manner. Moreover, it was about three times that EPS at noncytocxity concentration of 0.25 mg ml(-1) could sensitize doxorubicin(Dox)-induced growth inhibition of SGC-7901 cells after 24h treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624770     DOI: 10.1016/j.biortech.2007.05.049

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  30 in total

Review 1.  Application of microbial extracellular carbohydrate polymeric substances in food and allied industries.

Authors:  Onkar Nath Tiwari; Soumya Sasmal; Ajay Kumar Kataria; Indrama Devi
Journal:  3 Biotech       Date:  2020-04-28       Impact factor: 2.406

Review 2.  Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.

Authors:  Betty Schwartz; Yitzhak Hadar
Journal:  Ann Transl Med       Date:  2014-02

3.  Production of β-glucan exopolysaccharide lasiodiplodan by Lasiodiplodia theobromae CCT 3966 from corn bran acid hydrolysate.

Authors:  Rafael Rodrigues Philippini; Sabrina Evelin Martiniano; Paulo Ricardo Franco Marcelino; Anuj Kumar Chandel; Júlio César Dos Santos; Silvio Silvério Da Silva
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-18       Impact factor: 4.813

4.  Structural characterization and a novel water-soluble polysaccharide from Fomes Fomentarius.

Authors:  Qiang Zhang; Yue Li; Jie Shang; Ming Ye
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

5.  Improved simultaneous production of mycelial biomass and polysaccharides by submerged culture of Hericium erinaceum: optimization using a central composite rotatable design (CCRD).

Authors:  Eliza Malinowska; Wojciech Krzyczkowski; Grzegorz Łapienis; Franciszek Herold
Journal:  J Ind Microbiol Biotechnol       Date:  2009-09-27       Impact factor: 3.346

6.  Biochemical constituents of a wild strain of Schizophyllum commune isolated from Achanakmar-Amarkantak Biosphere Reserve (ABR), India.

Authors:  Arpita Mani Tripathi; Bhupendra N Tiwary
Journal:  World J Microbiol Biotechnol       Date:  2013-03-09       Impact factor: 3.312

7.  Exobiopolymer production of Ophiocordyceps dipterigena BCC 2073: optimization, production in bioreactor and characterization.

Authors:  Kanokarn Kocharin; Pranee Rachathewee; Jean-Jacques Sanglier; Wai Prathumpai
Journal:  BMC Biotechnol       Date:  2010-07-12       Impact factor: 2.563

8.  The effect of fermentation conditions on the structure and anti-tumor activity of polysaccharides from Cordyceps gunnii.

Authors:  Xiao-Cui Liu; Hongran Li; Tong Kang; Zhen-Yuan Zhu; Ying-Liang Liu; Hui-Qing Sun; Li-Chao Pan
Journal:  RSC Adv       Date:  2019-06-10       Impact factor: 4.036

9.  Fungal strain matters: colony growth and bioactivity of the European medicinal polypores Fomes fomentarius, Fomitopsis pinicola and Piptoporus betulinus.

Authors:  Philipp Dresch; Maria Nives D Aguanno; Katharina Rosam; Ulrike Grienke; Judith Maria Rollinger; Ursula Peintner
Journal:  AMB Express       Date:  2015-01-24       Impact factor: 3.298

10.  Recent developments in mushrooms as anti-cancer therapeutics: a review.

Authors:  Seema Patel; Arun Goyal
Journal:  3 Biotech       Date:  2011-11-25       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.